Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03553992 · ClinicalTrials.gov registry record · NA

An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
173
Enrollment target

NCT03553992: Completed NA study, sponsored by University of California, San Francisco.

NCT03553992 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 173 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03553992, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
173 participants
Enrollment target

Study Summary

The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexual or gender minorities (SGM), and use Facebook. Primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 months.

Primary Outcome

Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded.

Interventions

  • BEHAVIORAL POP-6:
  • BEHAVIORAL TSP-6:

Trial Details

FieldValue
Enrollment Target 173 participants
Start Date 2018-10-29
Est. Completion 2019-07-07
Phase NA

What the finished NCT03553992 record still lists

NCT03553992 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which POP-6: is the first listed.

NCT03553992 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03553992 about?

NCT03553992 is a clinical study titled "An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers". The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexu...

What is the current status of trial NCT03553992?

This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2018-10-29. Estimated completion is 2019-07-07.

What interventions are being tested in trial NCT03553992?

The interventions under investigation include: POP-6: (BEHAVIORAL), TSP-6: (BEHAVIORAL).

Who is sponsoring clinical trial NCT03553992?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03553992's enrollment target sits among peer trials

173 611th of 2000 higher than 1,389 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05568719 · 173 participants · Phase 3

    Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • NCT07070115 · 173 participants · NA

    Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

  • NCT07150832 · 173 participants · NA

    Efficacy of the I-CARE Digital Health Intervention

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03553992, the US trial registry maintained by the National Library of Medicine. NCT03553992 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.